To further evaluate in vivo whether EBER-induced inflammation via TLR3 promotes tumor development, we subjected EBV-positive NPC C666–1 cells to tumor formation assay in nude mice. The gene discussed is TLR3; the disease is nasopharyngeal carcinoma.